Home › Osteosarcoma
Pag-aaral pangklinika para sa Osteosarcoma na nagre-recruit sa U.S.
52 pag-aaral para sa Osteosarcoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- St. Louis, MO10 pag-aaral
- Memphis, TN10 pag-aaral
- Atlanta, GA10 pag-aaral
- Boston, MA9 pag-aaral
- Houston, TX9 pag-aaral
- Birmingham, AL7 pag-aaral
- Cincinnati, OH7 pag-aaral
- Mountain View, CA7 pag-aaral
- Los Angeles, CA7 pag-aaral
- Chicago, IL7 pag-aaral
- Dallas, TX6 pag-aaral
- Tampa, FL6 pag-aaral
- New York City, NY6 pag-aaral
- Washington, DC6 pag-aaral
- Philadelphia, PA6 pag-aaral
- Aurora, CO6 pag-aaral
- Durham, NC5 pag-aaral
- Honolulu, HI5 pag-aaral
- Milwaukee, WI5 pag-aaral
- The Bronx, NY5 pag-aaral
- Seattle, WA5 pag-aaral
- Charleston, SC4 pag-aaral
- Gainesville, FL4 pag-aaral
- Oakland, CA4 pag-aaral
- Orlando, FL4 pag-aaral
- Salt Lake City, UT4 pag-aaral
- Harrisburg, PA4 pag-aaral
- Clifton, NJ4 pag-aaral
- Columbus, OH4 pag-aaral
- Cleveland, OH4 pag-aaral
- Queens, NY4 pag-aaral
- Baltimore, MD4 pag-aaral
- Greenburgh, NY4 pag-aaral
- Portland, OR4 pag-aaral
- San Francisco, CA4 pag-aaral
- Nashville, TN3 pag-aaral
- Detroit, MI3 pag-aaral
- Richmond, VA3 pag-aaral
- San Diego, CA3 pag-aaral
- St. Petersburg, FL3 pag-aaral
Ayos sa estado
- Alabama7 pag-aaral
- Arizona4 pag-aaral
- Arkansas3 pag-aaral
- California17 pag-aaral
- Colorado6 pag-aaral
- Connecticut4 pag-aaral
- District of Columbia5 pag-aaral
- Florida10 pag-aaral
- Georgia10 pag-aaral
- Hawaii5 pag-aaral
- Illinois7 pag-aaral
- Louisiana3 pag-aaral
- Maryland5 pag-aaral
- Massachusetts9 pag-aaral
- Michigan6 pag-aaral
- Minnesota3 pag-aaral
- Missouri10 pag-aaral
- New Jersey6 pag-aaral
- New York11 pag-aaral
- North Carolina6 pag-aaral
- Ohio13 pag-aaral
- Oklahoma3 pag-aaral
- Oregon4 pag-aaral
- Pennsylvania9 pag-aaral
- Rhode Island3 pag-aaral
- South Carolina4 pag-aaral
- Tennessee12 pag-aaral
- Texas12 pag-aaral
- Utah4 pag-aaral
- Virginia3 pag-aaral
- Washington5 pag-aaral
- Wisconsin7 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06541262Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
Nagre-recruitPhase 2
Edad 12 hanggang 39 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04616560Safety and Feasibility of Intraoperative Visualization With Cytalux in Children
Nagre-recruitPhase 1
Edad 6 hanggang 17 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT06235125Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Nagre-recruitPhase 1
Edad 12 hanggang 50 · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT03093909The CATSINDO Trial - Clinical and Translational Study in Newly Diagnosed Osteosarcoma
Nagre-recruitPhase 2
Edad 7 hanggang 22 · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT07560826Evaluating Efficacy of B7-H3-CAR T Cells Administered at the End of Upfront Map Chemotherapy in Patients With Newly Diagnosed High-Risk Osteosarcoma
Nagre-recruitPhase 2
Hanggang edad 21 · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT07428993Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Nagre-recruitPhase 1
7 Months – 21 Years · Lahat ng kasarian · Na-update Okt 27, 2026 · NCT02508038AOH1996 for the Treatment of Refractory Solid Tumors
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 20, 2026 · NCT05227326Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
Nagre-recruitPhase 1
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07144254XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT06571734Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Nagre-recruitPhase 1
12 Months – 20 Years · Lahat ng kasarian · Na-update Okt 8, 2026 · NCT02013336Study to Assess Safety and Efficacy of Vactosertib in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma
Nagre-recruitPhase 1/2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 7, 2026 · NCT05588648Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study
Nagre-recruitPhase 2
Edad 12 pataas · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT05019703Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Nagre-recruitPhase 2
Edad 0 hanggang 50 · Lahat ng kasarian · Na-update Okt 6, 2026 · NCT07321912Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
Nagre-recruitPhase 1
Hanggang edad 50 · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06492954Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Nagre-recruitPhase 1/2
Edad 12 hanggang 40 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07725380Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Nagre-recruitPhase 1
Edad 5 hanggang 40 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06156410Clinical Orthopaedic Data Bank (Acute and Chronic)
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Set 3, 2026 · NCT00411060Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial
Nagre-recruitPhase 1
Edad 1 hanggang 75 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT07227571Losartan + Sunitinib in Treatment of Osteosarcoma
Nagre-recruitPhase 1
Edad 10 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT03900793Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Nagre-recruitPhase 3
Hanggang edad 50 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05235165Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Nagre-recruit
Lahat ng edad · Lahat ng kasarian · Na-update Ago 21, 2026 · NCT07514819SPEARHEAD-3 Pediatric Study
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.